metabolic anti-cancer agent ASCA101
Term · Oncology and biomedicine · MLC-T-ONC-015115
An agent targeting cancer metabolic processes, with potential antineoplastic activity. Upon administration, metabolic anti-cancer agent ASCA101 may disrupt one or more specific metabolic processes in cancer cells, which may lead to an increase in reactive oxygen species (ROS) and adenosine-5'-triphosphate (ATP) depletion. This causes apoptosis and prevents proliferation of susceptible cancers cells only while sparing normal, healthy cells.
| Identifier | MLC-T-ONC-015115 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015115",
"term": "metabolic anti-cancer agent ASCA101",
"field": "Oncology and biomedicine",
"definition": "An agent targeting cancer metabolic processes, with potential antineoplastic activity. Upon administration, metabolic anti-cancer agent ASCA101 may disrupt one or more specific metabolic processes in cancer cells, which may lead to an increase in reactive oxygen species (ROS) and adenosine-5'-triphosphate (ATP) depletion. This causes apoptosis and prevents proliferation of susceptible cancers cells only while sparing normal, healthy cells.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/metabolic-anti-cancer-agent-asca101/"
}
Record 10,898 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.